Arecoline Fundamentals Explained
The main end place was the safety and tolerability of sifalimumab. Treatment-emergent adverse activities (AEs) and serious AEs (SAEs) and their severity, outcome, and any connection towards the analyze medication have been recorded by the investigator all over the research. AEs were being deemed more likely to be associated with review medication i